ImmunoGen downgraded
September 21, 2015 at 19:16 PM EDT
Morgan
Stanley analyst Matthew Harrison downgraded Immunogen Inc. (Nasdaq: IMGN)
from an Equal Weight rating to an Underweight rating sending the stock price plummeting $2.33 to close at $12.32.
